Jenprad (Levosulpiride) is a therapeutic agent classified as an atypical neuroleptic with stereoselective antidopaminergic action. It is effective in treating both psychiatric conditions and gastrointestinal disturbances due to its unique ability to modulate dopamine receptors. At lower dosages, it functions to improve dopaminergic transmission to address depressive states and somatic disturbances, while at higher dosages, it acts as an antipsychotic by blocking postsynaptic dopamine receptors.
GENERIC NAME: Levosulpiride
COMPOSITION:
Each delayed-release capsule contains:
INDICATIONS:
Dyspepsia
Endogenous and reactive depressive states
Somatic disturbances
Acute and chronic schizophrenia (especially effective for negative symptoms)
PRESENTATION:
| Quantity | 150ml, 250ml, 30ml, 75ml |
|---|---|
| SKIN TYPE | Dry Skin |
